Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The influence of age at disease onset on future relapses and disability progression in multiple sclerosis patients on immunomodulatory treatment.

von Wyl V, Décard BF, Benkert P, Lorscheider J, Hänni P, Lienert C, Kuhle J, Derfuss T, Kappos L, Yaldizli Ö.

Eur J Neurol. 2020 Feb 25. doi: 10.1111/ene.14191. [Epub ahead of print]

PMID:
32097512
2.

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment.

Diebold M, Fischer-Barnicol B, Tsagkas C, Kuhle J, Kappos L, Derfuss T, Décard BF.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 11;6(5). pii: e594. doi: 10.1212/NXI.0000000000000594. Print 2019 Sep.

3.

PML with dimethyl fumarate-No convincing case against natalizumab.

Diebold M, Altersberger V, Décard BF, Kappos L, Derfuss T, Lorscheider J.

Mult Scler. 2019 Oct;25(12):1687-1688. doi: 10.1177/1352458519872894. Epub 2019 Aug 22. No abstract available.

PMID:
31436113
4.

A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence.

Diebold M, Altersberger V, Décard BF, Kappos L, Derfuss T, Lorscheider J.

Mult Scler. 2019 Oct;25(12):1682-1685. doi: 10.1177/1352458519852100. Epub 2019 Jun 18.

PMID:
31208265
5.

Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISH.

Streckmann F, Hess V, Bloch W, Décard BF, Ritzmann R, Lehmann HC, Balke M, Koliamitra C, Oschwald V, Elter T, Zahner L, Donath L, Roth R, Faude O.

BMJ Open. 2019 Apr 24;9(4):e024467. doi: 10.1136/bmjopen-2018-024467.

6.

A case of concomitant psoriasis and multiple sclerosis: Secukinumab and rituximab exert dichotomous effects in two autoimmune conditions.

Diebold M, Müller S, Derfuss T, Décard BF.

Mult Scler Relat Disord. 2019 Jun;31:38-40. doi: 10.1016/j.msard.2019.03.009. Epub 2019 Mar 9.

PMID:
30901703
7.

Extensive bilateral brain lesions in neuromyelitis optica spectrum disorders.

Décard BF, Derfuss T.

Mult Scler. 2018 Aug;24(9):1262-1263. doi: 10.1177/1352458518771888. Epub 2018 Apr 20. No abstract available.

PMID:
29676200
8.

Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.

Härtig F, Ross M, Dammeier NM, Fedtke N, Heiling B, Axer H, Décard BF, Auffenberg E, Koch M, Rattay TW, Krumbholz M, Bornemann A, Lerche H, Winter N, Grimm A.

Neurotherapeutics. 2018 Apr;15(2):439-451. doi: 10.1007/s13311-018-0609-4.

9.

Ultrasound and MRI of nerves for monitoring disease activity and treatment effects in chronic dysimmune neuropathies - Current concepts and future directions.

Décard BF, Pham M, Grimm A.

Clin Neurophysiol. 2018 Jan;129(1):155-167. doi: 10.1016/j.clinph.2017.10.028. Epub 2017 Nov 10. Review.

PMID:
29190522
10.

Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study.

Zimmer A, Coslovsky M, Abraham I, Décard BF.

Patient Prefer Adherence. 2017 Oct 20;11:1815-1830. doi: 10.2147/PPA.S140293. eCollection 2017.

11.

Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy.

Rattay TW, Winter N, Décard BF, Dammeier NM, Härtig F, Ceanga M, Axer H, Grimm A.

Eur J Neurol. 2017 Sep;24(9):1125-1134. doi: 10.1111/ene.13344. Epub 2017 Jul 5.

PMID:
28681489
12.

Ultrasound assessment of peripheral nerve pathology in neurofibromatosis type 1 and 2.

Winter N, Rattay TW, Axer H, Schäffer E, Décard BF, Gugel I, Schuhmann M, Grimm A.

Clin Neurophysiol. 2017 May;128(5):702-706. doi: 10.1016/j.clinph.2017.02.005. Epub 2017 Feb 20.

PMID:
28315612
13.

An unusual case of bilateral peroneal palsies due to fabellae.

Décard BF, Nagy S, Garcia M, Fuhr P.

Neurology. 2017 Feb 28;88(9):918. doi: 10.1212/WNL.0000000000003666. No abstract available.

PMID:
28242848
14.

Ultrasonographic reference values for peripheral nerves and nerve roots in the normal population of children and adolescents: study protocol for an observational-prospective trial.

Rasenack M, Décard BF, Schädelin S, Grimm A, Fischer D, Hafner P.

BMJ Open. 2016 Dec 9;6(12):e014662. doi: 10.1136/bmjopen-2016-014662.

15.

Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.

Décard BF, Thöne J, Haghikia A, Börnke C, Anders A, Lukas C, Gold R.

Mult Scler. 2017 Jan;23(1):123-125. doi: 10.1177/1352458516650522. Epub 2016 Jul 20.

PMID:
27430683
16.

Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.

Grimm A, Vittore D, Schubert V, Lipski C, Heiling B, Décard BF, Axer H.

Clin Neurophysiol. 2016 Jul;127(7):2618-24. doi: 10.1016/j.clinph.2016.04.009. Epub 2016 Apr 21.

PMID:
27291881
17.

Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.

Décard BF, Derfuss T.

Semin Neurol. 2016 Apr;36(2):128-39. doi: 10.1055/s-0036-1580720. Epub 2016 Apr 26. Review.

PMID:
27116719
18.

Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.

Meira M, Sievers C, Hoffmann F, Haghikia A, Rasenack M, Décard BF, Kuhle J, Derfuss T, Kappos L, Lindberg RL.

Neurol Neuroimmunol Neuroinflamm. 2016 Mar 31;3(3):e223. doi: 10.1212/NXI.0000000000000223. eCollection 2016 Jun.

19.

Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.

Grimm A, Vittore D, Schubert V, Rasenack M, Décard BF, Heiling B, Hammer N, Axer H.

J Neurol. 2016 Jun;263(6):1074-82. doi: 10.1007/s00415-016-8100-9. Epub 2016 Mar 26.

PMID:
27017343
20.

Nerve Hypertrophy in Primary Amyloidosis.

Rasenack M, Proebstel AK, Athanasopoulou IM, Décard BF, Grimm A.

Muscle Nerve. 2016 Sep;54(3):510-2. doi: 10.1002/mus.25113. Epub 2016 Apr 28. No abstract available.

PMID:
26999802
21.

Ultrasound of the nerves - An appropriate addition to nerve conduction studies to differentiate paraproteinemic neuropathies.

Athanasopoulou IM, Rasenack M, Grimm C, Axer H, Sinnreich M, Décard BF, Grimm A.

J Neurol Sci. 2016 Mar 15;362:188-95. doi: 10.1016/j.jns.2016.01.055. Epub 2016 Jan 26.

PMID:
26944145
22.

The modified ultrasound pattern sum score mUPSS as additional diagnostic tool for genetically distinct hereditary neuropathies.

Grimm A, Rasenack M, Athanasopoulou IM, Dammeier NM, Lipski C, Wolking S, Vittore D, Décard BF, Axer H.

J Neurol. 2016 Feb;263(2):221-230. doi: 10.1007/s00415-015-7953-7. Epub 2015 Nov 11.

PMID:
26559821
23.

Ultrasound and electrophysiologic findings in patients with Guillain-Barré syndrome at disease onset and over a period of six months.

Grimm A, Décard BF, Schramm A, Pröbstel AK, Rasenack M, Axer H, Fuhr P.

Clin Neurophysiol. 2016 Feb;127(2):1657-1663. doi: 10.1016/j.clinph.2015.06.032. Epub 2015 Jul 21.

PMID:
26220732
24.

Nerve ultrasound in Miller Fisher variant of Guillain-Barré syndrome.

Décard BF, Fladt J, Axer H, Fischer D, Grimm A.

Muscle Nerve. 2015 Dec;52(6):1106-10. doi: 10.1002/mus.24753. Epub 2015 Jul 24.

PMID:
26123539
25.

Hepatitis-E virus associated neuralgic amyotrophy with sustained plexus brachialis swelling visualized by high-resolution ultrasound.

Décard BF, Grimm A, Andelova M, Deman A, Banderet B, Garcia M, Fuhr P.

J Neurol Sci. 2015 Apr 15;351(1-2):208-210. doi: 10.1016/j.jns.2015.03.003. Epub 2015 Mar 6. No abstract available.

PMID:
25769655
26.

The Ultrasound pattern sum score - UPSS. A new method to differentiate acute and subacute neuropathies using ultrasound of the peripheral nerves.

Grimm A, Décard BF, Axer H, Fuhr P.

Clin Neurophysiol. 2015 Nov;126(11):2216-25. doi: 10.1016/j.clinph.2015.01.011. Epub 2015 Feb 3.

PMID:
25691156
27.

Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy.

Grimm A, Décard BF, Athanasopoulou I, Schweikert K, Sinnreich M, Axer H.

J Neurol. 2015;262(4):870-80. doi: 10.1007/s00415-015-7648-0. Epub 2015 Jan 28.

PMID:
25626722
28.

Ultrasonography of the peripheral nervous system in the early stage of Guillain-Barré syndrome.

Grimm A, Décard BF, Axer H.

J Peripher Nerv Syst. 2014 Sep;19(3):234-41. doi: 10.1111/jns.12091.

PMID:
25418824
29.

Ultrasound of the peripheral nerves in systemic vasculitic neuropathies.

Grimm A, Décard BF, Bischof A, Axer H.

J Neurol Sci. 2014 Dec 15;347(1-2):44-9. doi: 10.1016/j.jns.2014.09.017. Epub 2014 Sep 18.

PMID:
25262016
30.

Muscle ultrasonography as an additional diagnostic tool for the diagnosis of amyotrophic lateral sclerosis.

Grimm A, Prell T, Décard BF, Schumacher U, Witte OW, Axer H, Grosskreutz J.

Clin Neurophysiol. 2015 Apr;126(4):820-7. doi: 10.1016/j.clinph.2014.06.052. Epub 2014 Aug 21.

PMID:
25204706
31.

Clinical reasoning: a 48-year-old woman with progressive spastic-ataxic gait.

Kerasnoudis A, Décard BF, Gold R.

Neurology. 2013 Sep 10;81(11):e75-80. doi: 10.1212/WNL.0b013e3182a43ad9.

PMID:
24019389
32.

Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.

Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, Décard BF, Thum T, Gold R.

Neurology. 2012 Nov 27;79(22):2166-70. doi: 10.1212/WNL.0b013e3182759621. Epub 2012 Oct 17.

PMID:
23077021
33.

Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.

Décard BF, von Ahsen N, Grunwald T, Streit F, Stroet A, Niggemeier P, Schottstedt V, Riggert J, Gold R, Chan A.

J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1170-3. doi: 10.1136/jnnp-2012-303068. Epub 2012 Aug 11.

PMID:
22888143
34.

Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.

Décard BF, Haghikia A, Tönnes C, Thöne J, Lukas C, Chan A, Gold R.

Mult Scler. 2013 Feb;19(2):249-51. doi: 10.1177/1352458512448268. Epub 2012 May 17.

PMID:
22596228
35.

Wheels within wheels: multifocal autoimmune myelitis in a woman with Huntington's disease.

Haghikia A, Décard BF, Hellwig K, Kraus P, Gold R.

J Neurol. 2012 Sep;259(9):1973-5. doi: 10.1007/s00415-012-6484-8. Epub 2012 Mar 30. No abstract available.

PMID:
22460588
36.

Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis.

Chan A, Decard BF, Franke C, Grummel V, Zhou D, Schottstedt V, Toyka KV, Hemmer B, Gold R.

Mult Scler. 2010 Oct;16(10):1189-92. doi: 10.1177/1352458510376406. Epub 2010 Aug 4.

PMID:
20685767

Supplemental Content

Loading ...
Support Center